Currently, as a result of its healthcare competence, expertise, and research capacity, CHUP allocates 16 national reference centers and is included in 6 European networks as "Healthcare Provider", which allows access to and leverages large clinical studies and the development of new drugs.

 

For further information about the institution and its professionals go to:

The portal on rare diseases and orphan drugs.